Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Sylvia K Wood is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants & Projects
- 5 Finished
-
Effectiveness and Implementation of a Brief Motivational Intervention to Increase Physical Activity for World Trade Center Health Program Cancer Survivors
Ginex, P. (PI), Boffetta, P. (CoPI), Friedberg, F. (CoPI), Luft, B. J. (CoPI), Sillice, M. A. (CoPI) & Wood, S. K. (CoPI)
Centers for Disease Control and Prevention
07/1/24 → 06/30/26
Project: Research
-
A Multicenter, Open-Label, Phase 2, Safety and Efficacy Study of the Bruton's Tryosine Kinase (Btk) Inhibitor, PCI-32765, in Subjects with Relapsed or Refractory de Novo Diffuse Large B-Cell Lymphoma
Schuster, M. (PI), Gabig, T. (CoPI), Lan, F. (CoPI), Wood, S. K. (CoPI), Kiner-Strachan, B. (CoPI) & Masood, A. (CoPI)
09/26/14 → 09/26/15
Project: Research
-
Phase II Randomized, Multicenter Study of Treatment-Free Remission in Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Patients Who Achieve and Sustain MR4.5 After Switching to Nilotinib
Schuster, M. (PI), Gabig, T. (CoPI), Lan, F. (CoPI), Wood, S. K. (CoPI), Kiner-Strachan, B. (CoPI) & Masood, A. (CoPI)
Novartis Pharmaceuticals Corporation
10/7/13 → 05/10/17
Project: Research
-
A Single-Arm, Multicenter, Nilotinib Treatment-Free Remission Study in Patients with BCR-ABL1 Positive Chronic Myelogenous Leukemia in Chronic Phase Who Have Achieved Durable Minimal Residual Disease (MRD) Status on First Line Nilotinib...
Schuster, M. (PI), Gabig, T. (CoPI), Lan, F. (CoPI), Wood, S. K. (CoPI), Kiner-Strachan, B. (CoPI) & Masood, A. (CoPI)
Novartis Pharmaceuticals Corporation
10/2/13 → 06/26/15
Project: Research
-
A Phase 3 Multicenter Randomized Open Label Study to Compare the Efficacy & Safety of Pomalidomide, Bortezomib & Low Dose Dexamethasone Versus Bortezomib & Low-Dose Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma
Schuster, M. (PI), Gabig, T. (CoPI), Lan, F. (CoPI), Wood, S. K. (CoPI), Kiner-Strachan, B. (CoPI) & Masood, A. (CoPI)
06/25/13 → 02/19/17
Project: Research
-
Utilization Rates and Factors Associated with Adoption of Complementary and Alternative Medicine Practices in the US
Nemesure, B., Thakur, C., Mermelstein, L. & Wood, S. K., Jan 1 2026, In: Journal of Evidence-Based Integrative Medicine. 31Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Reclaiming Self-Balancing on a Tightrope Across Time a grounded theory of transition to survivorship in older adult blood cancer survivors
Wood, S. K., Jan 2025, In: Journal of Advanced Nursing. 81, 1, p. 366-382 17 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Utilization of complementary, alternative, and integrative medicine practices among US adults with and without a diagnosis of cancer
Nemesure, B., Wood, S. K. & Mermelstein, L., Jul 2025, In: Supportive Care in Cancer. 33, 7, 582.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Physical activity interventions for cancer-related fatigue: A scoping review of randomized controlled trials from a Nursing Science Precision Health Model perspective
Ginex, P. K., Wood, S. K., Sivakumaran, K., Babatunde, I., Yu, T., Gibbs, K. D. V. & Morgan, R. L., Nov 1 2023, In: Nursing Outlook. 71, 6, 102052.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Keeping the Nurse in the Nurse Practitioner: Returning to Our Disciplinary Roots of Knowing in Nursing
Wood, S. K., Jan 1 2020, In: Advances in Nursing Science. 43, 1, p. 50-61 12 p.Research output: Contribution to journal › Review article › peer-review
16 Scopus citations